Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-05-08 4:01 pm Purchase |
2024-05-01 | 13D | Fresh Tracks Therapeutics, Inc. FRTX |
Exploration Capital, LLC | 1,273,024 21.300% |
376,024 (+41.92%) |
Filing History |
| 2024-01-17 8:37 pm Purchase |
2024-01-17 | 13G | Fresh Tracks Therapeutics, Inc. FRTX |
Exploration Capital, LLC | 897,000 15.000% |
897,000 (New Position) |
Filing History |
| 2023-11-27 6:01 pm Purchase |
2023-11-17 | 13G | Fresh Tracks Therapeutics, Inc. FRTX |
Exploration Capital Fund LP | 597,000 9.990% |
597,000 (New Position) |
Filing History |
| 2023-02-13 5:24 pm Sale |
2022-12-31 | 13G | Brickell Biotech, Inc. BBI |
Ionic Ventures LLC | 0 0.000% |
-135,444 (Position Closed) |
Filing History |
| 2022-02-03 3:37 pm Sale |
2021-12-31 | 13G | Brickell Biotech, Inc. BBI |
Ionic Ventures LLC | 135,444 5.300% |
-26,468 (-16.35%) |
Filing History |
| 2021-11-03 12:45 pm Purchase |
2021-10-28 | 13G | Brickell Biotech, Inc. BBI |
Ionic Ventures LLC | 161,913 6.330% |
57,289 (+54.76%) |
Filing History |
| 2021-07-22 08:59 am Purchase |
2021-07-22 | 13G | Brickell Biotech, Inc. BBI |
Ionic Ventures LLC | 104,623 5.700% |
104,623 (New Position) |
Filing History |
| 2021-02-16 09:54 am Purchase |
2020-12-31 | 13G | Brickell Biotech, Inc. BBI |
CVI Investments, Inc. | 62,459 4.900% |
19,569 (+45.63%) |
Filing History |
| 2021-02-11 4:30 pm Sale |
2020-12-31 | 13G | Brickell Biotech, Inc. BBI |
BIOTECHNOLOGY VALUE FUND L P | 0 0.000% |
-14,757 (Position Closed) |
Filing History |
| 2020-09-24 3:47 pm Purchase |
2020-09-14 | 13D | Brickell Biotech, Inc. BBI |
Palisade Concentrated Equity Partnership II LP | 23,853 3.860% |
1,336 (+5.94%) |
Filing History |
| 2020-06-26 4:39 pm Purchase |
2020-06-18 | 13G | Brickell Biotech, Inc. BBI |
Armistice Capital, LLC | 29,583 4.990% |
29,583 (New Position) |
Filing History |
| 2020-06-26 10:50 am Purchase |
2020-06-17 | 13G | Brickell Biotech, Inc. BBI |
CVI Investments, Inc. | 42,890 7.900% |
42,890 (New Position) |
Filing History |